CVE-2023-6517 in MİA-MED
Summary
by MITRE • 02/08/2024
Exposure of Sensitive Information Due to Incompatible Policies vulnerability in Mia Technology Inc. MİA-MED allows Collect Data as Provided by Users.
This issue affects MİA-MED: before 1.0.7.
If you want to get best quality of vulnerability data, you may have to visit VulDB.
Analysis
by VulDB Data Team • 05/20/2026
The vulnerability identified as CVE-2023-6517 represents a critical exposure of sensitive information through incompatible policy implementations within the MİA-MED software platform developed by Mia Technology Inc. This security flaw specifically manifests in the collection and handling of user-provided data, creating potential avenues for unauthorized access to confidential information. The vulnerability affects all versions of MİA-MED prior to version 1.0.7, indicating that organizations utilizing older iterations of this medical device software may be at risk of data compromise. The issue stems from insufficient policy enforcement mechanisms that fail to properly restrict access to sensitive user data, creating a scenario where information that should remain protected becomes accessible to unauthorized parties.
The technical root cause of this vulnerability lies in the improper implementation of access control policies within the software architecture. When users provide data through the MİA-MED platform, the system fails to adequately validate or enforce security policies that would normally prevent unauthorized access to this information. This misconfiguration creates a gap in the security framework where sensitive medical data, patient information, and potentially other confidential details can be collected and exposed without proper authorization. The vulnerability operates at the intersection of data collection and policy enforcement, where the software's inability to properly distinguish between authorized and unauthorized data access creates a persistent security risk.
From an operational perspective, this vulnerability presents significant risks to healthcare organizations and medical facilities that rely on MİA-MED for patient data management. The exposure of sensitive information could lead to serious privacy violations, regulatory non-compliance, and potential legal consequences under healthcare data protection regulations such as HIPAA or GDPR. Medical facilities may face reputational damage, financial penalties, and increased liability risks when patient data is compromised through such policy incompatibilities. The vulnerability also creates opportunities for malicious actors to exploit the system for identity theft, medical fraud, or other cybercriminal activities that target sensitive healthcare information.
The impact of this vulnerability extends beyond immediate data exposure to encompass broader security implications for healthcare IT infrastructure. Organizations utilizing affected versions of MİA-MED must consider the potential for cascading security issues, where compromised data can be used as a foothold for further attacks within the network. The vulnerability aligns with CWE-200, which addresses "Information Exposure," and represents a failure in proper data protection mechanisms. From an ATT&CK framework perspective, this vulnerability maps to techniques involving credential access and data exposure, potentially enabling adversaries to gather intelligence about system users and their activities. Organizations should implement immediate remediation measures including updating to version 1.0.7 or later, conducting thorough security assessments of affected systems, and implementing additional monitoring controls to detect potential unauthorized access attempts. The vulnerability underscores the critical importance of maintaining up-to-date security policies and proper access control mechanisms in healthcare environments where patient data protection is paramount.